NOVO NORDISK CFO: WEGOCY PILL LAUNCH IN US, UK, AND UAE IS MAINLY IN SELF-PAY, 90% OF SCRIPTS
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)